Duration of heart failure and the risk of atrial fibrillation: different mechanisms at different times?

Autor Rankin, Andrew C, Workman, Antony J
Vydáno 2009

Do hypoxaemia or hypercapnoea predispose to atrial fibrillation in breathing disorders, and if so, how?

Autor Workman, Antony J, Rankin, Andrew C
Vydáno 2010

Cellular bases for human atrial fibrillation

Autor Workman, Antony J., Kane, Kathleen A., Rankin, Andrew C.
Vydáno 2008

Electrophysiological effects of 5-hydroxytryptamine on isolated human atrial myocytes, and the influence of chronic β-adrenoceptor blockade

Autor Pau, Davide, Workman, Antony J, Kane, Kathleen A, Rankin, Andrew C
Vydáno 2003

Electrophysiological and arrhythmogenic effects of 5-hydroxytryptamine on human atrial cells are reduced in atrial fibrillation

Autor Pau, Davide, Workman, Antony J., Kane, Kathleen A., Rankin, Andrew C.
Vydáno 2007

Post-operative atrial fibrillation is influenced by beta-blocker therapy but not by pre-operative atrial cellular electrophysiology

Autor Workman, Antony J, Pau, Davide, Redpath, Calum J, Marshall, Gillian E, Russell, Julie A, Kane, Kathleen A, Norrie, John, Rankin, Andrew C
Vydáno 2006

Atrial cellular electrophysiological changes in patients with ventricular dysfunction may predispose to AF

Autor Workman, Antony J, Pau, Davide, Redpath, Calum J, Marshall, Gillian E, Russell, Julie A, Norrie, John, Kane, Kathleen A, Rankin, Andrew C
Vydáno 2008

Effects of human atrial ionic remodelling by β-blocker therapy on mechanisms of AF: a computer simulation

Autor Kharche, Sanjay R, Stary, Tomas, Colman, Michael A, Biktasheva, Irina V, Workman, Antony J, Rankin, Andrew C, Holden, Arun V, Zhang, Henggui
Vydáno v Europace (2014)